Cargando…
Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219842/ http://dx.doi.org/10.1371/journal.pone.0113001 |
Ejemplares similares
-
Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
por: Figueiredo, Carlyn A., et al.
Publicado: (2014) -
Correction: Contribution of Pannexin1 to Experimental Autoimmune
Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013) -
Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
por: Straubel, Diana, et al.
Publicado: (2018) -
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015) -
Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
por: Horiuchi, Hiroshi, et al.
Publicado: (2021)